Mestinonn.
/ˈmɛstɪnɒn/, U.S. /ˈmɛstɪnɑn/ Pharmacology.
A proprietary name for: an oral or injectable formulation of the cholinesterase inhibitor pyridostigmine bromide, used chiefly to treat myasthenia gravis.
ΚΠ
1953 Trade Marks Jrnl. 11 Nov. 1032/1 Mestinon.
1955 Sci. News Let. 9 July 29/1 The new drug is known by the trade-name Mysuran chloride. It has a longer lasting effect than either neostigmine or Mestinon, two other drugs that have been used in myasthenia gravis.
1968 New Eng. Jrnl. Med. 1 Feb. 266/2 Pyridostigmine bromide (Mestinon) produced a prompt increase in muscular strength.
1981 M. C. Gerald Pharmacol. (ed. 2) vii. 135 Other cholinesterase inhibitors used for the chronic treatment of myasthenia gravis include ambenonium (Mytelase) and pyridostigmine (Mestinon).
1997 Pediatr. Surg. Internat. 12 113 All 15 patients [with juvenile myasthenia gravis] were placed on pyridostigmine bromide (Mestinon).
This is a new entry (OED Third Edition, September 2001; most recently modified version published online March 2022).
<
n.1953- valer
- valer-
- valeraceto-nitril
- valeracetonitril
- valeral
- valeraldehyd
- valeraldine
- valeramide
- valeranilide
- valerate
- valerates
- valerene
- valerian
- valerian family
- valerian oil
- valerian order
- valerian root
- valerian tea
- valerian tribe
- valerian-worts
- valerianaceous
- valerianate
- valerianic
- valerians
- valerianworts